Ninety One (UK)
IDXX icon

Ninety One (UK)’s Idexx Laboratories IDXX Stock Holding History

Ninety One (UK)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.79M Sell
18,599
-2,302
-11% -$1.29M 0.02% 179
2026
Q1 		$11.7M Sell
20,901
-5,749
-22% -$3.69M 0.03% 158
2025
Q4 		$18M Sell
26,650
-8,912
-25% -$6.07M 0.04% 148
2025
Q3 		$22.7M Sell
35,562
-22,366
-39% -$13.6M 0.05% 131
2025
Q2 		$31.1M Sell
57,928
-6,681
-10% -$3.19M 0.07% 113
2025
Q1 		$27.1M Sell
64,609
-6,423
-9% -$2.79M 0.08% 121
2024
Q4 		$29.4M Buy
71,032
+21,041
+42% +$9.23M 0.08% 120
2024
Q3 		$25.3M Buy
49,991
+16,990
+51% +$8.25M 0.07% 124
2024
Q2 		$16.1M Sell
33,001
-1,826
-5% -$917K 0.04% 141
2024
Q1 		$18.8M Hold
34,827
– – 0.05% 138
2023
Q4 		$19.3M Buy
34,827
+14,247
+69% +$6.69M 0.06% 130
2023
Q3 		$9M Hold
20,580
– – 0.03% 150
2023
Q2 		$10.3M Sell
20,580
-208
-1% -$99.7K 0.03% 154
2023
Q1 		$10.4M Sell
20,788
-1,015
-5% -$486K 0.03% 152
2022
Q4 		$8.89M Buy
+21,803
New +$8.46M 0.03% 159

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ninety One (UK)'s IDXX Position: Q2 2026 in Review

Ninety One (UK) reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $1.29M and leaving 18,599 shares worth $9.79M. The position accounts for 0.02% of the portfolio, ranked #179.

Ninety One (UK) first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $31.1M in Q2 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ninety One (UK) held 18,599 shares of Idexx Laboratories worth $9.79M as of Q2 2026.
  • Ninety One (UK) sold 2,302 Idexx Laboratories shares in Q2 2026, an estimated $1.29M.
  • Idexx Laboratories made up 0.02% of Ninety One (UK)'s portfolio in Q2 2026, its #179 holding.
  • Ninety One (UK) first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Ninety One (UK)'s Idexx Laboratories position peaked at $31.1M in Q2 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.